Classification of clinics by deprescribing performance
As part of our implementation analysis, we will classify clinics as low, moderate, or high performers on deprescribing, characterized as the number of participants for which clinically meaningful deprescribing occurred divided by the number of eligible participants. Clinically meaningful will be defined as discontinuation, sustained discontinuation, or dose reduction at the 6-month timepoint.